This topic contains a solution. Click here to go to the answer

Author Question: The acronym FLaReS is a mnemonic that helps us remember the rules that can be used to test a claim. ... (Read 36 times)

saraeharris

  • Hero Member
  • *****
  • Posts: 546
The acronym FLaReS is a mnemonic that helps us remember the rules that can be used to test a claim. Which of the following is NOT one of these rules?
 
  A) falsifiability
  B) logic
  C) replicability
  D) societal acceptance

Question 2

Which of the following can be done to increase the likelihood that a chemical reaction will take place?
 
  A) decrease the average speed of the reacting molecules
  B) induce more collisions between reacting molecules
  C) remove all the water from the reaction mixture
  D) break the reaction up into a series of steps



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

qytan

  • Sr. Member
  • ****
  • Posts: 336
Answer to Question 1

D

Answer to Question 2

B




saraeharris

  • Member
  • Posts: 546
Reply 2 on: Aug 27, 2018
YES! Correct, THANKS for helping me on my review


shewald78

  • Member
  • Posts: 340
Reply 3 on: Yesterday
Gracias!

 

Did you know?

In most climates, 8 to 10 glasses of water per day is recommended for adults. The best indicator for adequate fluid intake is frequent, clear urination.

Did you know?

Patients who have undergone chemotherapy for the treatment of cancer often complain of a lack of mental focus; memory loss; and a general diminution in abilities such as multitasking, attention span, and general mental agility.

Did you know?

Barbituric acid, the base material of barbiturates, was first synthesized in 1863 by Adolph von Bayer. His company later went on to synthesize aspirin for the first time, and Bayer aspirin is still a popular brand today.

Did you know?

Aspirin may benefit 11 different cancers, including those of the colon, pancreas, lungs, prostate, breasts, and leukemia.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library